Exploring the impact of chronic intermittent EU-GMP certified Cannabis sativa L. therapy and its relevance in a rat model of aging.

Ivona-Maria Tudorancea, Gabriela-Dumitrita Stanciu, Carmen Solcan, Mitica Ciorpac, Andrei Szilagyi, Daniela-Carmen Ababei, Raluca-Maria Gogu, Bogdan-Ionel Tamba

Advanced Research and Development Center for Experimental Medicine "Prof, Ostin C. Mungiu" - CEMEX, "Grigore T. Popa" University of Medicine and Pharmacy of Iasi, Iasi, Romania.Advanced Research and Development Center for Experimental Medicine "Prof, Ostin C. Mungiu" - CEMEX, "Grigore T. Popa" University of Medicine and Pharmacy of Iasi, Iasi, Romania. · pubmed

Paper

Abstract

Aging is a multifaceted process marked by the progressive accumulation of cellular damage in various tissues, resulting in a decline in physiological functions. The primary aim of aging research is to identify compounds that can delay or mitigate these detrimental changes. As cannabis legalization becomes more widespread and with limited empirical studies on its effects in the aging human population, there is a pressing need for research into the impact of Cannabis and cannabinoids on healthy aging and age-related diseases.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper investigates the effects of chronic intermittent cannabis therapy on aging in a rat model. This research is relevant as it explores potential interventions that could address the biological processes associated with aging rather than merely treating age-related symptoms.

Author of this paper? Send a correction.